Cargando…
New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
Atherosclerosis (AS) features include progressive hardening and reduced elasticity of arteries. AS is the leading cause of morbidity and mortality. An increasing amount of evidence showed that epigenetic modifications on genes serve are a main cause of several diseases, including AS. Histone deacety...
Autores principales: | Luan, Yi, Liu, Hui, Luan, Ying, Yang, Yang, Yang, Jing, Ren, Kai-Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068932/ https://www.ncbi.nlm.nih.gov/pubmed/35529430 http://dx.doi.org/10.3389/fphar.2022.863677 |
Ejemplares similares
-
Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases
por: Yang, Yang, et al.
Publicado: (2023) -
Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus
por: Yang, Yang, et al.
Publicado: (2022) -
New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke
por: Wei, Ziqing, et al.
Publicado: (2022) -
Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases
por: Luan, Yi, et al.
Publicado: (2021) -
Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment
por: Sun, Yichen, et al.
Publicado: (2022)